Skip to main content
. Author manuscript; available in PMC: 2009 Nov 15.
Published in final edited form as: Cancer Res. 2008 Nov 15;68(22):9512–9518. doi: 10.1158/0008-5472.CAN-08-0553

Figure 3.

Figure 3

Relationship between HOMA index and triglycerides (panel A and B) or leptin (panel C and D) by BMI category according to treatment (TAM: tamoxifen+placebo or tamoxifen+fenretinide; FEN: fenretinide+placebo or fenretinide+tamoxifen) drugs as regards the. Lines for triglycerides represent the fitted values of the interactions between treatment and HOMA index, obtained from repeated-measure analysis considering year I and II, after adjusting for baseline value, time and treatment